期刊
FEBS LETTERS
卷 587, 期 5, 页码 398-403出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2013.01.020
关键词
alpha(2)-Macroglobulin; Extracellular chaperone; Amyloid disease; Human lysozyme; A beta(1 42)
资金
- Bill Gole Fellowship (Motor Neurone Disease Research Institute of Australia)
- BBSRC [BB/E019927/1]
- Wellcome Trust
- BBSRC [BB/E019927/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/E019927/1] Funding Source: researchfish
alpha(2)-Macroglobulin (alpha M-2) is an extracellular chaperone that inhibits amorphous and fibrillar protein aggregation. The reaction of alpha M-2 with proteases results in an 'activated' conformation, where the proteases become covalently-linked within the interior of a cage-like structure formed by alpha M-2. This study investigates, the effect of activation on the ability of alpha M-2 to inhibit amyloid formation by A beta(1-42) and I59T human lysozyme and shows that protease-activated alpha M-2 can act via two distinct mechanisms: (i) by trapping proteases that remain able to degrade polypeptide chains and (ii) by a chaperone action that prevents misfolded clients from continuing along the amyloid forming pathway. Structured summary of protein interactions: A beta(1-42) and A beta(1-42) bind by fluorescence technology (View interaction) I59T lysozyme and I59T lysozyme bind by light scattering (View interaction) I59T lysozyme and I59T lysozyme bind by fluorescence technology (View interaction) Alpha-lactalbumin and Alpha-lactalbumin bind by fluorescence technology (View interaction) I59T lysozyme and I59T lysozyme bind by electron microscopy (View interaction) A beta(1-42) and A beta(1-42) bind by electron microscopy (View interaction) (C) 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据